Newsweek от 31,07,2015 — тема номера — рак.
Целый ряд интересных статей. Цитата из статьи о быстром росте цен:
«This week, more than 100 of the nation’s leading cancer doctors, including several past
presidents of the American Society of Clinical Oncology and James Allison, the scientist whose basic research led to the development of Yervoy, released a statement in the Mayo
Clinic Proceedings that called for reforms to rein in costs, including changing laws they believe have allowed prices to balloon.
Over the past decade, cancer drug prices have skyrocketed—going from $5,000 to $10,000 for a year’s treatment before 2000 to more than $100,000 by 2012, according to another Mayo Clinic study. (Average household income in the U.S. dropped by about 8 percent during
the same period.) While some patients are insulated from these price hikes by their insurers, many others, including those on Medicare, are on the hook for 20 percent copays for prescription drugs, which can translateto upward of $20,000 in yearly out-of-pocket costs. “Hardly anyone in this country can afford that,” says Dr. Peter Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center in New York. “People are putting themselves into bankruptcy or trading the wealth they would pass on to their heirs for a few more months of life.”»
Американцам, конечно, приходится много доплачивать за эти лекарства. Но у них эти лекарства есть… Но у них хоть часть цены покрывается, да и доходы в США у людей немалые, сравнительно с нашими.
У нас «контроль над ценами» устроен так, что цены выше, чем в США, и больные вынуждены оплачивать их полностью. Если им не сподобилось стать министрами или иными большими чиновниками. Одним — изба со скайпом для получения совета, другим — столичные клиники бесплатно и с любыми лекарствами.
Василий Власов
